Connection

Majid Marjani to Male

Back to Details
This is a "connection" page, showing publications Majid Marjani has written about Male.
Majid Marjani
Connection Strength
0.081
Male
  1. The relationship between serum 25-hydroxyvitamin D levels and the severity of COVID-19 disease and its mortality. Sci Rep. 2021 09 02; 11(1):17594.
    View in: PubMed
    Score: 0.013
  2. Diagnosis of COVID-19 by Serology in Admitted Patients with Negative RT-PCR Assay. Iran J Allergy Asthma Immunol. 2021 Aug 07; 20(4):394-401.
    View in: PubMed
    Score: 0.013
  3. Immune cell profiling and antibody responses in patients with COVID-19. BMC Infect Dis. 2021 Jul 05; 21(1):646.
    View in: PubMed
    Score: 0.013
  4. Increased Serum Levels of Soluble TNF-a Receptor Is Associated With ICU Mortality in COVID-19 Patients. Front Immunol. 2021; 12:592727.
    View in: PubMed
    Score: 0.003
  5. No clinical benefit of high dose corticosteroid administration in patients with COVID-19: A preliminary report of a randomized clinical trial. Eur J Pharmacol. 2021 Apr 15; 897:173947.
    View in: PubMed
    Score: 0.003
  6. Dynamic Changes of Lymphocyte Subsets in the Course of COVID-19. Int Arch Allergy Immunol. 2021; 182(3):254-262.
    View in: PubMed
    Score: 0.003
  7. Serum cytokine levels of COVID-19 patients after 7 days of treatment with Favipiravir or Kaletra. Int Immunopharmacol. 2021 Apr; 93:107407.
    View in: PubMed
    Score: 0.003
  8. Comparative evaluation of SARS-CoV-2 IgG assays against nucleocapsid and spike antigens. Hum Antibodies. 2021; 29(2):109-113.
    View in: PubMed
    Score: 0.003
  9. Combination therapy of IFNß1 with lopinavir-ritonavir, increases oxygenation, survival and discharging of sever COVID-19 infected inpatients. Int Immunopharmacol. 2021 Mar; 92:107329.
    View in: PubMed
    Score: 0.003
  10. Evaluating the effects of Intravenous Immunoglobulin (IVIg) on the management of severe COVID-19 cases: A randomized controlled trial. Int Immunopharmacol. 2021 Jan; 90:107205.
    View in: PubMed
    Score: 0.003
  11. Diffuse alveolar damage and thrombotic microangiopathy are the main histopathological findings in lung tissue biopsy samples of COVID-19 patients. Pathol Res Pract. 2020 Oct; 216(10):153228.
    View in: PubMed
    Score: 0.003
  12. Promising effects of tocilizumab in COVID-19: A non-controlled, prospective clinical trial. Int Immunopharmacol. 2020 Nov; 88:106869.
    View in: PubMed
    Score: 0.003
  13. Successful Treatment of Covid-19 Associated Cytokine Release Syndrome with Colchicine. A Case Report and Review of Literature. Immunol Invest. 2021 Nov; 50(8):884-890.
    View in: PubMed
    Score: 0.003
  14. Subcutaneous administration of interferon beta-1a for COVID-19: A non-controlled prospective trial. Int Immunopharmacol. 2020 Aug; 85:106688.
    View in: PubMed
    Score: 0.003
  15. Diagnostic accuracy of interferon (IFN)-? inducible protein 10 (IP-10) as a biomarker for the discrimination of active and latent tuberculosis. Mol Biol Rep. 2019 Dec; 46(6):6263-6269.
    View in: PubMed
    Score: 0.003
  16. An adult autosomal recessive chronic granulomatous disease patient with pulmonary Aspergillus terreus infection. BMC Infect Dis. 2018 Nov 08; 18(1):552.
    View in: PubMed
    Score: 0.003
  17. Distribution scheme of antituberculosis drug resistance among HIV patients in a referral centre over 10 years. J Glob Antimicrob Resist. 2017 12; 11:116-119.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.